Flunisolide and Psyllium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flunisolide (flunisolide) and Psyllium (blond psyllium). Common drug interactions include retinoschisis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Flunisolide and Psyllium. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Flunisolide?

Flunisolide has active ingredients of flunisolide. It is often used in allergies. eHealthMe is studying from 2,318 Flunisolide users. Check the latest studies of Flunisolide.

What is Psyllium?

Psyllium has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 4,262 Psyllium users. Check the latest studies of Psyllium.

On Jul, 19, 2026

41 people who take Flunisolide and Psyllium together, and have interactions are studied.

Flunisolide and Psyllium drug interactions.

What are the common drug interactions of Flunisolide and Psyllium, by gender? *:

female:

Retinoschisis (eye disease characterized by the abnormal splitting of the retina's neurosensory layers)
Vitreous adhesions
Chronic kidney disease
Renal failure (kidney dysfunction)
Cataract (clouding of the lens inside the eye)
Drug ineffective
Fall
Foot fracture
Hypersomnia (excessive daytime sleepiness (eds))
Hypertension (high blood pressure)

male:

Anxiety
Back disorder
Renal failure (kidney dysfunction)
Thrombosis (formation of a blood clot inside a blood vessel)
Abnormal behaviour
Ankle fracture
Aphasia (damage to the parts of the brain that control language)
Atelectasis (partial or complete collapse of the lung)
Bone density decreased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)

What are the common drug interactions of Flunisolide and Psyllium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Palpitations (feelings or sensations that your heart is pounding or racing)
Retinoschisis (eye disease characterized by the abnormal splitting of the retina's neurosensory layers)
Vitreous adhesions
Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Ankle fracture
Anxiety
Decreased activity
Depression
Emotional distress

60+:

Drug level increased
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Cataract (clouding of the lens inside the eye)
Cerebral atrophy (decrement in size of brain)
Confusional state
Cough
Dyspnoea (difficult or laboured respiration)
Exostosis (formation of new bone on the surface of a bone)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 39.02%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 39.02%
Pain: 10 people, 24.39%
High Blood Pressure: 8 people, 19.51%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 17.07%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 17.07%
Abdominal Discomfort: 6 people, 14.63%
Asthma: 6 people, 14.63%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 5 people, 12.20%
Back Pain: 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Flunisolide and Psyllium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously